NCT04520009

Brief Summary

Randomize Everyone is a research project to develop new informatics systems and statistical methods for supporting randomization processes in EHR systems to do comparative effectiveness research. Two demonstration projects are being conducted in the Dartmouth Hitchcock Medical Center, designed to evaluate different weight loss interventions and common practices in the treatment of chronic low back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2020

Completed
7 months until next milestone

First Posted

Study publicly available on registry

August 20, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

October 23, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 7, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 27, 2021

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

March 1, 2024

Completed
Last Updated

March 1, 2024

Status Verified

July 1, 2023

Enrollment Period

10 months

First QC Date

January 10, 2020

Results QC Date

June 21, 2022

Last Update Submit

July 31, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Compliance Rate With Assigned Treatment

    Compliance with assigned treatment as measured by presence of appropriate surgical discharge instructions.

    Upon completion of surgery approximately 24 days post-randomization

  • Percentage Eligible Patients Participating in Study

    Percentage of those identified as being eligible who were enrolled.

    1 day, during the recruitment period from October 23 2020 to August 7, 2021

Study Arms (2)

Activity Restriction

ACTIVE COMPARATOR

Discharge orders for activity restriction

Behavioral: Activity Restriction

Activity As Tolerated

ACTIVE COMPARATOR

Discharge orders written for activity as tolerated

Behavioral: Activity as Tolerated

Interventions

Standard post-operative activity instructions (i.e., no bending, twisting, or lifting more than 10 lbs for 4 weeks, no return to work until cleared to do so).

Activity Restriction

Instructions advising activity as tolerated and return to work based on patient discretion

Activity As Tolerated

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (\>18) able to consent
  • Sufficient fluency in English
  • Indications for discectomy
  • Able to restrict activities or to resume activities as tolerated

You may not qualify if:

  • Pregnant women
  • Prisoners
  • Children (\<18).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dartmouth-HItchcock

Lebanon, New Hampshire, 03756, United States

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Limitations and Caveats

Primary limitations of the trial include limited enrollment compared to the original goal of 60 randomized patients due in part to the limitations in elective surgery during the Covid-19 pandemic. By design, the study is pragmatic, and primarily intended to evaluated methodologies for embedding randomization in the electronic record system of a regional health care center.

Results Point of Contact

Title
Tor D. Tosteson, ScD
Organization
Dartmouth Geisel School of Medicine

Study Officials

  • Tor Tosteson, ScD

    Dartmouth

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 10, 2020

First Posted

August 20, 2020

Study Start

October 23, 2020

Primary Completion

August 7, 2021

Study Completion

October 27, 2021

Last Updated

March 1, 2024

Results First Posted

March 1, 2024

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

No plans at this time share IPD

Locations